Lila Gilis

663 total citations
16 papers, 245 citations indexed

About

Lila Gilis is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Lila Gilis has authored 16 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Lila Gilis's work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Lila Gilis is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Lila Gilis collaborates with scholars based in France, India and United States. Lila Gilis's co-authors include Fiorenza Barraco, Hélène Labussière‐Wallet, Florence Ader, Xavier Thomas, Sophie Ducastelle-Leprêtre, Mauricette Michallet, Gilles Salles, Marie Y. Detrait, L. Thomas and Anne‐Marie Schott and has published in prestigious journals such as Blood, Frontiers in Immunology and BMJ Open.

In The Last Decade

Lila Gilis

14 papers receiving 239 citations

Peers

Lila Gilis
Sohtaro Mine Japan
S. Ciappi Italy
Gabrielle Roth-Guépin France
Priti Tewari United States
Chantip Dang‐Heine Germany
Christina Chang United States
Paula Yurie Tanaka Brazil
Joshua A. Hill United States
Caitlin W. Elgarten United States
Sweta Shah United States
Sohtaro Mine Japan
Lila Gilis
Citations per year, relative to Lila Gilis Lila Gilis (= 1×) peers Sohtaro Mine

Countries citing papers authored by Lila Gilis

Since Specialization
Citations

This map shows the geographic impact of Lila Gilis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lila Gilis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lila Gilis more than expected).

Fields of papers citing papers by Lila Gilis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lila Gilis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lila Gilis. The network helps show where Lila Gilis may publish in the future.

Co-authorship network of co-authors of Lila Gilis

This figure shows the co-authorship network connecting the top 25 collaborators of Lila Gilis. A scholar is included among the top collaborators of Lila Gilis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lila Gilis. Lila Gilis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Balsat, Marie, Hélène Labussière‐Wallet, Vincent Alcazer, et al.. (2025). Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasms. Blood. 146(Supplement 1). 5570–5570.
2.
Pleșa, Adriana, Gaëlle Fossard, Fiorenza Barraco, et al.. (2022). Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy. 29(1). 38.e1–38.e9. 4 indexed citations
3.
Dubois, Valérie, Hélène Labussière‐Wallet, Fabienne Venet, et al.. (2022). Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Frontiers in Immunology. 13. 841470–841470. 15 indexed citations
4.
Nicolas‐Virelizier, Emmanuelle, Chiara Russo, Olivia Pérol, et al.. (2021). Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial. BMJ Open. 11(6). e046409–e046409. 1 indexed citations
5.
Boyle, Helen, et al.. (2019). Qualitative, Exploratory, and Multidimensional Study of Telepresence Robots for Overcoming Social Isolation of Children and Adolescents Hospitalized in Onco-Hematology. Journal of Adolescent and Young Adult Oncology. 9(1). 90–95. 7 indexed citations
6.
Michallet, Mauricette, Mohamad Sobh, Emmanuelle Nicolas‐Virelizier, et al.. (2019). Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study. Blood. 134(Supplement_1). 5817–5817. 1 indexed citations
7.
8.
Ranchon, Florence, Lila Gilis, Vérane Schwiertz, et al.. (2015). Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(4). 723–730. 58 indexed citations
9.
10.
Gilis, Lila, Geneviève Billaud, Sophie Ducastelle-Leprêtre, et al.. (2014). High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 49(5). 664–670. 104 indexed citations
11.
Michallet, Mauricette, Mohamad Sobh, Mohamed Elhamri, et al.. (2014). Therapeutic Management of Acute Myeloid Leukemia Patients after Stratification on Age, Prognosis and Allogeneic Hematopoietic Stem Cell Transplantation Eligibility. Blood. 124(21). 3691–3691. 1 indexed citations
12.
Michallet, Mauricette, Mohamad Sobh, Marie Y. Detrait, et al.. (2014). Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients. Blood. 124(21). 3892–3892. 1 indexed citations
13.
Michallet, Mauricette, Mohamad Sobh, Stéphane Morisset, et al.. (2013). Significant Impact Of Iron Chelation After Allogeneic Hematopoetic Stem Cell Transplantation On Disease Recurrence: Potential Anti-Leukemic Activity. Blood. 122(21). 180–180. 6 indexed citations
14.
15.
16.
Sève, P., Anne‐Marie Schott, Michel Pavic, et al.. (2009). Sarcoidosis and Melanoma: A Referral Center Study of 1,199 Cases. Dermatology. 219(1). 25–31. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sohtaro Mine Breakdown of academic impact, for papers by S. Ciappi Breakdown of academic impact, for papers by Gabrielle Roth-Guépin Breakdown of academic impact, for papers by Priti Tewari Breakdown of academic impact, for papers by Chantip Dang‐Heine Breakdown of academic impact, for papers by Christina Chang Breakdown of academic impact, for papers by Paula Yurie Tanaka Breakdown of academic impact, for papers by Joshua A. Hill Breakdown of academic impact, for papers by Caitlin W. Elgarten Breakdown of academic impact, for papers by Sweta Shah
Rankless by CCL
2026